News
PLRZ
0.9950
+22.54%
0.1830
Weekly Report: what happened at PLRZ last week (1111-1115)?
Weekly Report · 10h ago
Weekly Report: what happened at PLRZ last week (1104-1108)?
Weekly Report · 11/11 12:56
Weekly Report: what happened at PLRZ last week (1028-1101)?
Weekly Report · 11/04 12:50
Opening Day: Polyrizon, Gelteq debut in quiet IPO week
TipRanks · 11/03 11:30
Polyrizon 959K share IPO priced at $4.38
TipRanks · 10/30 15:06
Polyrizon opens at $1.64, IPO priced at $4.38 per unit
TipRanks · 10/30 15:05
POLYRIZON ANNOUNCES CLOSING OF $4.2 MILLION INITIAL PUBLIC OFFERING
Reuters · 10/30 14:28
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/30 10:16
Polyrizon Shares Open For Trade At $1.64/Unit; IPO Priced At $4.38/Unit
Benzinga · 10/29 15:11
Reported Earlier, Polyrizon Prices $4.2M Initial Public Offering Of 958,903 Units At $4.38/Unit
Benzinga · 10/29 06:06
More
Webull provides a variety of real-time PLRZ stock news. You can receive the latest news about Polyrizon Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PLRZ
Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..